Risk of thromboembolic phenomena in patients with inflammatory bowel disease

被引:7
|
作者
Suarez Ferrer, Cristina [1 ]
Vera Mendoza, Maria Isabel [1 ]
Amo San Roman, Leticia [1 ]
Gonzalez Lama, Yago [1 ]
Calvo Moya, Marta [1 ]
Garcia Casas, Mercedes [1 ]
Abreu Garcia, Luis [1 ]
机构
[1] Hosp Univ Puerta de Hierro, Serv Gastroenterol & Hepatol, Madrid, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2012年 / 35卷 / 09期
关键词
Thromboembolic phenomena; Inflammatory bowel disease; Risk of thrombosis; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM;
D O I
10.1016/j.gastrohep.2012.07.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Inflammatory bowel disease (IBD) is an independent risk factor for thromboembolic phenomena (TEP). We evaluated the prevalence and the possible risk factors associated with developing TEP in patients with IBD in our center. Material and methods: Data were retrospectively collected from January 1995 to December 2011 from 23 patients. A total of 61% were diagnosed with Crohn's disease (CD) and 39% with ulcerative colitis (UC) according to routine criteria. Results: When the Montreal classification was used, 58% of the patients with CD had an inflammatory pattern (B1), 25% a stenosing pattern (B2) and 17% a fistulizing pattern (B3). Half the patients had ileocolic involvement (L3), one-third had colonic involvement (L2) and the remainder had Heal involvement (L1). Among patients with UC according to the Montreal classification, 78% had extensive colitis (E3), 11% had left colonic involvement (E2) and 11% had proctocolitis (El). During the event, almost half the patients with UC had severe inflammatory activity (S3; 44%), 33% had mild-moderate activity (51: 22%, S2: 11%) and only 22% were in remission (SO). Overall, at the time of the TEP, 48% of the patients had mild-moderate activity and 22% had severe activity. Likewise, 44% were hospitalized at the time of the event. In UC, an increase in the prevalence of TEP was found in admitted patients (66%). None of the patients had a family history of TER two patients (9%) had associated thrombophilia and 26% were active smokers. There were no TEP during pregnancy. Only one patient was taking contraceptive pills when the event occurred. The most frequent forms of TEP were deep vein thrombosis of the legs (55%) followed by pulmonary thromboembolism (25%). Conclusions: TEP are relatively frequent in patients with IBD, with a strong impact on morbidity and mortality. In our series, risk factors for these events were more extensive involvement (any of the groups) and severe inflammatory activity. No significant association between classical risk factors such as the use of contraceptives, pregnancy, coagulation disorders or smoking and the risk of TEP were found. (C) 2012 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 50 条
  • [1] Thromboembolic Events in Patients with Inflammatory Bowel Disease
    Algahtani, Farjah H.
    Farag, Youssef M. K.
    Aljebreen, Abdulrahman M.
    Alazzam, Nahla A.
    Aleem, Aamer S.
    Jabri, Fouad F.
    Rajab, Mohammad H.
    Shoukri, Mohamed M.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (06): : 423 - 427
  • [2] Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview
    Gala, Dhir
    Newsome, Taylor
    Roberson, Nicole
    Lee, Soo Min
    Thekkanal, Marvel
    Shah, Mili
    Kumar, Vikash
    Bandaru, Praneeth
    Gayam, Vijay
    DISEASES, 2022, 10 (04)
  • [3] Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
    Setyawan, Juliana
    Mu, Fan
    Zichlin, Miriam L.
    Billmyer, Emma
    Downes, Nathaniel
    Yang, Hongbo
    Azimi, Nassir
    Strand, Vibeke
    Yarur, Andres
    ADVANCES IN THERAPY, 2022, 39 (01) : 738 - 753
  • [4] Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments
    Garcia, Jose Luis Rueda
    Benitez, Jose Manuel
    Rey, Iria Baston
    Sard, Margalida Calafat
    Ferrer, Cristina Suarez
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2025, 48 (01):
  • [5] The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Arvanitakis, Konstantinos D.
    Arvanitaki, Alexandra D.
    Karkos, Christos D.
    Zintzaras, Elias A.
    Germanidis, Georgios S.
    ANNALS OF GASTROENTEROLOGY, 2021, 34 (05): : 680 - +
  • [6] Thromboembolic complications in inflammatory bowel disease
    Kohoutova, Darina
    Moravkova, Paula
    Kruzliak, Peter
    Bures, Jan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (04) : 489 - 498
  • [7] Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study
    Weng, Meng-Tzu
    Park, Sang Hyoung
    Matsuoka, Katsuyoshi
    Tung, Chien-Chih
    Lee, Jae Yong
    Chang, Chin-Hao
    Yang, Suk-Kyun
    Watanabe, Mamoru
    Wong, Jau-Min
    Wei, Shu-Chen
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (08) : 1791 - 1800
  • [8] Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease
    Nelson, Alfred D.
    Fluxa, Daniela
    Caldera, Freddy
    Farraye, Francis A.
    Hashash, Jana G.
    Kroner, Paul T.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2597 - 2603
  • [9] Cerebral Thromboembolic Events in Pediatric Patients with Inflammatory Bowel Disease
    Barclay, A. R.
    Keightley, J. M.
    Horrocks, I.
    Garrick, V.
    McGrogan, P.
    Russell, R. K.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (04) : 677 - 683
  • [10] Thromboembolic complications in inflammatory bowel disease
    Darina Kohoutova
    Paula Moravkova
    Peter Kruzliak
    Jan Bures
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 489 - 498